Axelar Receives Financing for a Phase I/II Clinical Trial on Cancer Patients With the New Anti-Cancer Drug AXL1717
STOCKHOLM, Sweden, June 12 /PRNewswire/ -- Axelar AB today announced that the company has received financing from Östersjöstiftelsen (the Foundation for Baltic and East European Studies) and…